These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 31859321)

  • 1. Transforming lanthanide and actinide chemistry with nanoparticles.
    Pallares RM; Abergel RJ
    Nanoscale; 2020 Jan; 12(3):1339-1348. PubMed ID: 31859321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomedical Applications of Lanthanide Nanomaterials, for Imaging, Sensing and Therapy.
    Zhang Q; O'Brien S; Grimm J
    Nanotheranostics; 2022; 6(2):184-194. PubMed ID: 34976593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amine-Terminated Phenanthroline Diimides as Aqueous Masking Agents for Am(III)/Eu(III) Separation: An Alternative Ligand Design Strategy for Water-Soluble Lanthanide/Actinide Chelating Ligands.
    Cao H; Kang Y; Li B; Liu Y; Bao M; Li H; Zheng Y; Wang L; Weng C; Tang X; Wang L; Xu C
    Inorg Chem; 2024 Jun; 63(23):10511-10518. PubMed ID: 38768636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lanthanides: Applications in Cancer Diagnosis and Therapy.
    Teo RD; Termini J; Gray HB
    J Med Chem; 2016 Jul; 59(13):6012-24. PubMed ID: 26862866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical characterization of heavy actinides and light transactinides - Experimental achievements at JAEA.
    Nagame Y; Sato TK
    Proc Jpn Acad Ser B Phys Biol Sci; 2024; 100(3):165-189. PubMed ID: 38462500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategy for photostable proximity bioassays using lanthanides.
    Haushalter JP; Faris GW
    Appl Opt; 2007 Apr; 46(10):1918-23. PubMed ID: 17356638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient discrimination of transplutonium actinides by
    Pallares RM; An DD; Deblonde GJ; Kullgren B; Gauny SS; Jarvis EE; Abergel RJ
    Chem Sci; 2021 Mar; 12(14):5295-5301. PubMed ID: 34168780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the aromaticity of actinide compounds.
    Badri Z; Foroutan-Nejad C
    Nat Rev Chem; 2024 Jul; 8(7):551-560. PubMed ID: 38907002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of density-based separation of Ce and Hf intermetallics in liquid Bi.
    Seo G; Shin HW; Park J
    Chemosphere; 2024 Jul; 363():142882. PubMed ID: 39025315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chelating decorporation agents for internal contamination by actinides: Designs, mechanisms, and advances.
    Li Y; Li B; Chen L; Dong J; Xia Z; Tian Y
    J Inorg Biochem; 2023 Jan; 238():112034. PubMed ID: 36306597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actinide Decorporation: A Review on Chelation Chemistry and Nanocarriers for Pulmonary Administration.
    Lai EPC; Li C
    Radiat Res; 2022 Oct; 198(4):430-443. PubMed ID: 35943882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro and In Vivo Evaluation of DTPA-HPMA Copolymers as Potential Decorporating Agents for Prophylactic Therapy of Actinide Contamination.
    Alshehri S; Fan W; Zhang W; Garrison JC
    Radiat Res; 2022 Oct; 198(4):357-367. PubMed ID: 35913891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unveiling Hidden Shake-Up Features in the Uranyl M
    Ehrman JN; Shumilov K; Jenkins AJ; Kasper JM; Vitova T; Batista ER; Yang P; Li X
    JACS Au; 2024 Mar; 4(3):1134-1141. PubMed ID: 38559711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecularly Targeted Lanthanide Nanoparticles for Cancer Theranostic Applications.
    Ferro-Flores G; Ancira-Cortez A; Ocampo-García B; Meléndez-Alafort L
    Nanomaterials (Basel); 2024 Jan; 14(3):. PubMed ID: 38334567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient and selective capture of thorium ions by a covalent organic framework.
    Liu X; Gao F; Jin T; Ma K; Shi H; Wang M; Gao Y; Xue W; Zhao J; Xiao S; Ouyang Y; Ye G
    Nat Commun; 2023 Aug; 14(1):5097. PubMed ID: 37607947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand?
    Pallares RM; Abergel RJ
    Front Med (Lausanne); 2022; 9():1020188. PubMed ID: 36619636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and multi-scale properties of PuO
    Virot M; Dumas T; Cot-Auriol M; Moisy P; Nikitenko SI
    Nanoscale Adv; 2022 Nov; 4(23):4938-4971. PubMed ID: 36504736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying Toxicity Mechanisms Associated with Early Lanthanide Exposure through Multidimensional Genome-Wide Screening.
    Pallares RM; An DD; Hébert S; Loguinov A; Proctor M; Villalobos JA; Bjornstad KA; Rosen CJ; Vulpe CD; Abergel RJ
    ACS Omega; 2022 Sep; 7(38):34412-34419. PubMed ID: 36188298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covalency in actinide(iv) hexachlorides in relation to the chlorine K-edge X-ray absorption structure.
    Sergentu DC; Autschbach J
    Chem Sci; 2022 Mar; 13(11):3194-3207. PubMed ID: 35414875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic, Prognostic, and Therapeutic Use of Radiopharmaceuticals in the Context of SARS-CoV-2.
    Pallares RM; Abergel RJ
    ACS Pharmacol Transl Sci; 2021 Feb; 4(1):1-7. PubMed ID: 33615159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.